Dear Colleagues,

It is my great pleasure and honour to invite you to the 20^th Annual Scientific Conference. The theme this year is “Advancements & Novel Approaches to Cardiometabolic Syndrome”.

Cardiometabolic Syndrome (CMS) is a group of interrelated risk factors that increase an individual's chances of developing cardiovascular disease and type 2 diabetes mellitus. These risk factors include obesity, insulin resistance, high blood pressure and dyslipidemia.

In recent years, there have been significant updates in the understanding and management of CMS. Researchers have discovered new mechanisms underlying the development and progression of CMS. Additionally, advances in diagnostic tools, such as imaging techniques and biomarkers, have improved the identification and monitoring of CMS.

The treatment and prevention of CMS have also undergone important developments, with emphasis on lifestyle modifications, such as regular physical activity and a healthy diet. Pharmacological interventions, such as new classes of antidiabetic and lipid-lowering drugs, have shown promising results in reducing cardiovascular risk in individuals with CMS.

As Singapore moves from reactively caring for those who are sick, towards proactively preventing individuals from falling ill in the Healthier SG initiative, these updates are timely in providing valuable insights and opportunities for improving the diagnosis, management and outcomes of this complex syndrome.

We trust that this will be an enriching and enlightening conference, and we look forward to welcoming you to the meeting.